Vitamin D, and kidney disease

Electrolyte and Blood Pressure

Volumn 9, Issue 1, 2011, Pages 1-6

  Kim, Hyung Soo ^a   Chung, Wookyung ^a   Kim, Sejoong ^a  

^a Gachon University   (South Korea)

Author keywords

Deficiency; Renal insufficiency, chronic; Vitamin D

Indexed keywords

PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D; VITAMIN D RECEPTOR;

BLOOD VESSEL CALCIFICATION; CHRONIC KIDNEY DISEASE; DIALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; HYPERPARATHYROIDISM; KIDNEY DISEASE; MORTALITY; PREVALENCE; REVIEW; RISK FACTOR; VITAMIN D DEFICIENCY;

EID: 80052852122     PISSN: 17385997     EISSN: 20929935     Source Type: Journal    
DOI: 10.5049/EBP.2011.9.1.1     Document Type: Review

References (27)

1. Norman AW, Bouillon R: Vitamin D nutritional policy needs a vision for the future. Exp Biol Med (Maywood) 235:1034-1045, 2010
2. Zittermann A, Schleithoff SS, Koerfer R: Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 94:483-492, 2005 (Pubitemid 41555486)
3. Choi N: Kidney and phosphate metabolism. Electrolyte Blood Press 6:77-85, 2008
4. Bergwitz C, Juppner H: Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 61:91-104, 2010
5. Garcia-Canton C, Bosch E, Ramirez A, et al.: Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant 26:2250-2256, 2011
6. Adragao T, Pires A, Lucas C, et al.: A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 19:1480-1488, 2004 (Pubitemid 38786742)
7. Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW: New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 132:245-250, 1997 (Pubitemid 27311017)
8. Razzaque MS: The dualistic role of vitamin D in vascular calcifications. Kidney Int 79:708-714, 2011
9. Maalouf NM: The noncalciotropic actions of vitamin D: recent clinical developments. Curr Opin Nephrol Hypertens 17:408-415, 2008
10. Motiwala SR, Wang TJ: Vitamin D and cardiovascular disease. Curr Opin Nephrol Hypertens 20:345-353, 2011
11. Henry HL, Bouillon R, Norman AW, et al.: 14th Vitamin D Workshop consensus on vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 121:4-6, 2010
12. Forrest KY, Stuhldreher WL: Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res 31:48-54, 2011
13. Hintzpeter B, Mensink GB, Thierfelder W, Muller MJ, Scheidt-Nave C: Vitamin D status and health correlates among German adults. Eur J Clin Nutr 62:1079-1089, 2008
14. Rockell JE, Skeaff CM, Williams SM, Green TJ: Serum 25-hydroxyvitamin D concentrations of New Zealanders aged 15 years and older. Osteoporos Int 17:1382-1389, 2006 (Pubitemid 44127325)
15. Choi HS, Oh HJ, Choi H, et al.: Vitamin D insufficiency in Korea - a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab 96:643-651, 2011
16. Levin A, Bakris GL, Molitch M, et al.: Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31-38, 2007 (Pubitemid 44967731)
17. Evenepoel P, Meijers B, Viaene L, et al.: Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism. Clin J Am Soc Nephrol 5:1268-1276, 2010
18. Lee YM, Park SW, Kim JS, et al.: 25-Hydroxyvitamin D status in patients with chronic kidney disease in a single center. Korean J Nephrol 29:458-464, 2010
19. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int (Suppl 113):S1-130, 2009
20. Melamed ML, Michos ED, Post W, Astor B: 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168:1629-1637, 2008
21. Dobnig H, Pilz S, Scharnagl H, et al.: Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168:1340-1349, 2008 (Pubitemid 351930842)
22. Autier P, Gandini S: Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 167:1730-1737, 2007 (Pubitemid 47403059)
23. Kandula P, Dobre M, Schold JD, Schreiber MJ, Jr., Mehrotra R, Navaneethan SD: Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 6:50-62, 2011
24. Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K: Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med 168:397-403, 2008 (Pubitemid 351350586)
25. Drechsler C, Verduijn M, Pilz S, et al.: Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant 26:1024-1032, 2011
26. Teng M, Wolf M, Ofsthun MN, et al.: Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 16:1115-1125, 2005 (Pubitemid 41710323)
27. Wolf M, Betancourt J, Chang Y, et al.: Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 19:1379-1388, 2008